Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells

制定针对代谢脆弱的人体细胞能量衰竭的策略

基本信息

  • 批准号:
    10622496
  • 负责人:
  • 金额:
    $ 64.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-08-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary Disrupted energy metabolism is a central driver of dysfunction and death in a wide range of diseases, and may also contribute to aging. Energy failure, or insufficient energy to support normal function, can lead to neurodegenerative diseases, ischemia and heart failure, while an imbalance in energy production may contribute to cancer. As such, boosting energy levels has great therapeutic potential to improve cellular function and survival. However, there are only anecdotal examples of how to increase or preserve cellular ATP levels. To address this critical unmet need for anti-aging and energy-focused therapeutics, we developed an innovative high throughput screen that uses a fluorescent biosensor to measure ATP levels in individual cells, and used it to identify genes and pathways that regulate ATP levels. In this proposal, we will test our central hypothesis that increasing ATP can enhance the function and survival of vulnerable cells, but the efficacy depends on the mechanism by which ATP is increased. The overall objectives of our proposed study are to define the most robust mechanisms to increase cellular energy levels, and to determine if increasing ATP boosts the function and survival of human cells that are susceptible to diseases of energy failure. We will accomplish these objectives in two specific aims. (1) We will use metabolomics, transcriptomics and assays of energy production and consumption to determine the broad mechanisms by which energy levels can be increased. (2) We will determine if increasing the ATP level can enhance the function and survival of human neurons and cardiomyocytes. Overall, these studies will i) determine the broad cellular mechanisms by which cellular energy levels can be increased, and ii) begin to assess the therapeutic potential of increasing energy levels to protect against energy failure in metabolically vulnerable human cells.
项目总结

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function.
  • DOI:
    10.1371/journal.pbio.3001753
  • 发表时间:
    2022-09
  • 期刊:
  • 影响因子:
    9.8
  • 作者:
    Bennett, Neal K.;Nakaoka, Hiroki J.;Laurent, Danny;Okimoto, Ross A.;Sei, Yoshitaka;Horvai, Andrew E.;Bivona, Trever G.;Ten Hoeve, Johanna;Graeber, Thomas G.;Nakamura, Ken;Nakamura, Jean L.
  • 通讯作者:
    Nakamura, Jean L.
NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62.
  • DOI:
    10.1038/s41467-023-44033-0
  • 发表时间:
    2023-12-19
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Furthmann, Nikolas;Bader, Verian;Angersbach, Lena;Blusch, Alina;Goel, Simran;Sanchez-Vicente, Ana;Krause, Laura J.;Chaban, Sarah A.;Grover, Prerna;Trinkaus, Victoria A.;van Well, Eva M.;Jaugstetter, Maximilian;Tschulik, Kristina;Damgaard, Rune Busk;Saft, Carsten;Ellrichmann, Gisa;Gold, Ralf;Koch, Arend;Englert, Benjamin;Westenberger, Ana;Klein, Christine;Jungbluth, Lisa;Sachse, Carsten;Behrends, Christian;Glatzel, Markus;Hartl, F. Ulrich;Nakamura, Ken;Christine, Chadwick W.;Huang, Eric J.;Tatzelt, Jorg;Winklhofer, Konstanze F.
  • 通讯作者:
    Winklhofer, Konstanze F.
Biallelic pathogenic variants in COX11 are associated with an infantile-onset mitochondrial encephalopathy.
  • DOI:
    10.1002/humu.24453
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Rius, Rocio;Bennett, Neal K.;Bhattacharya, Kaustuv;Riley, Lisa G.;Yuksel, Zafer;Formosa, Luke E.;Compton, Alison G.;Dale, Russell C.;Cowley, Mark J.;Gayevskiy, Velimir;Al Tala, Saeed M.;Almehery, Abdulrahman A.;Ryan, Michael T.;Thorburn, David R.;Nakamura, Ken;Christodoulou, John
  • 通讯作者:
    Christodoulou, John
The PINK1 advantage: recycling mitochondria in times of trouble?
PINK1 的优势:在遇到麻烦时回收线粒体?
  • DOI:
    10.1080/15548627.2021.1998872
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    13.3
  • 作者:
    Doric,Zak;Li,Huihui;Nakamura,Ken
  • 通讯作者:
    Nakamura,Ken
SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19.
人IPSC衍生的心脏细胞的SARS-COV-2感染反映了COVID-19患者心脏的细胞病变特征。
  • DOI:
    10.1126/scitranslmed.abf7872
  • 发表时间:
    2021-04-21
  • 期刊:
  • 影响因子:
    17.1
  • 作者:
    Perez-Bermejo JA;Kang S;Rockwood SJ;Simoneau CR;Joy DA;Silva AC;Ramadoss GN;Flanigan WR;Fozouni P;Li H;Chen PY;Nakamura K;Whitman JD;Hanson PJ;McManus BM;Ott M;Conklin BR;McDevitt TC
  • 通讯作者:
    McDevitt TC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEN NAKAMURA其他文献

KEN NAKAMURA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEN NAKAMURA', 18)}}的其他基金

Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
  • 批准号:
    10417270
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
  • 批准号:
    10237384
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
Determining how neural activity impairs bioenergetics in PD pathogenesis
确定神经活动如何损害 PD 发病机制中的生物能学
  • 批准号:
    9257471
  • 财政年份:
    2015
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    8289649
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    8501699
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    8212953
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    8231455
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    7796870
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
Regulation of mitochondrial morphology by alpha-synuclein
α-突触核蛋白对线粒体形态的调节
  • 批准号:
    7659837
  • 财政年份:
    2009
  • 资助金额:
    $ 64.58万
  • 项目类别:
GLUTATHIONE AND DOPAMINERGIC NEURONAL SURVIVAL
谷胱甘肽和多巴胺能神经元的存活
  • 批准号:
    6185105
  • 财政年份:
    2000
  • 资助金额:
    $ 64.58万
  • 项目类别:

相似海外基金

The relationship between blood based bioenergetics and muscle function, mobility, and aging
基于血液的生物能学与肌肉功能、活动能力和衰老之间的关系
  • 批准号:
    10363365
  • 财政年份:
    2022
  • 资助金额:
    $ 64.58万
  • 项目类别:
The relationship between blood based bioenergetics and muscle function, mobility, and aging
基于血液的生物能学与肌肉功能、活动能力和衰老之间的关系
  • 批准号:
    10569677
  • 财政年份:
    2022
  • 资助金额:
    $ 64.58万
  • 项目类别:
Coordinated mechanisms to rescue bioenergetics and sarcopenia in aging
拯救衰老过程中生物能学和肌肉减少症的协调机制
  • 批准号:
    10672292
  • 财政年份:
    2022
  • 资助金额:
    $ 64.58万
  • 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
  • 批准号:
    10426408
  • 财政年份:
    2021
  • 资助金额:
    $ 64.58万
  • 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
  • 批准号:
    10317378
  • 财政年份:
    2021
  • 资助金额:
    $ 64.58万
  • 项目类别:
PPARG regulates osteocyte bioenergetics and function during aging
PPARG 在衰老过程中调节骨细胞生物能和功能
  • 批准号:
    10634739
  • 财政年份:
    2021
  • 资助金额:
    $ 64.58万
  • 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
  • 批准号:
    10480897
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
  • 批准号:
    10083227
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
Investigating the novel role of acetylation in cardiac mitochondrial bioenergetics and function in the aging heart
研究乙酰化在心脏线粒体生物能学和衰老心脏功能中的新作用
  • 批准号:
    10471062
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
Bioenergetics of Metformin Action and Aging
二甲双胍作用与衰老的生物能学
  • 批准号:
    10432123
  • 财政年份:
    2020
  • 资助金额:
    $ 64.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了